250
Participants
Start Date
December 16, 2020
Primary Completion Date
March 9, 2022
Study Completion Date
December 31, 2026
Transcatheter Aortic Valve Implantation/Replacement
The device is placed in patients heart at the level of aortic valve through a transfemoral access from femoral groin as indicated in device IFU
Hospital Clinico Universitario Valladolid, Valladolid
"A.O.U Policlinico G.Rodolico - San Marco", Catania
Aarhus Universitetshospital, Aarhus
Rigshospitalet, Copenhagen
Odense University Hospital, Odense
Kerckhoff-Klinik GmbH Herz und Thorax Zentrum Abteilung Kardiologie/Kardiochirurgie, Bad Nauheim
HDZ Bad Oeynhausen, Bad Oeynhausen
St.-Johannes-Hospital, Dortmund
Universitätsklinik Regensburg, Regensburg
San Raffaele Hospital, Milan
Azienda Ospedaliera Pisana, Pisa
Erasmus Medical Center, Rotterdam
UMC Utrecht, Utrecht
Hospital Clinico de Santiago, Santiago de Compostela
Lund University, Cardiology department, Lund
Karolinska Universitetssjukhuset, Stockholm
Universitätsspital Zürich, Zurich
Liverpool Heart and Chest Hospital, Liverpool
John Radcliffe Hospital, Oxford
Lead Sponsor
Boston Scientific Corporation
INDUSTRY